MEDLAB AMERICAS

MEDLAB, the world’s largest medical laboratory exhibition, is now in America!

The US Diagnostics & Medical Laboratories sectors (in vivo and in vitro) revenue was $53 billion in May 2016 and is worth 40-45% ofthe global market, making North America the largest region worldwide for this industry.

With annual growth projected at 0.9%, the demand for an annual networking opportunity that covers all areas of medical laboratories is high. Introducing MEDLAB Americas - with year-on-year growth within the MEDLAB portfolio, from the Middle East, to Asia and Africa, the MEDLAB exhibition has proven success on an international scale.

>> See the MEDLAB portfolio

Bringing together the leaders in the medical laboratory industry to exchange ideas and, most importantly, network face-to-face for enhanced business opportunities in the industry, MEDLAB Americas will feature as a dedicated area onsite at FIME 2017 from August 8-10 alongside 3 CME-accredited laboratory medicine and diagnostics conferences.

 

CLINICAL MICROBIOLOGY
August 8, 2017

HAEMATOLOGY
August 9, 2017

POINT OF CARE TESTING
August 10, 2017

This track on Clinical Microbiology will focus on the most current research related to the laboratory diagnosis of human infections, role of the laboratory in both the management of infectious diseases and epidemiology of infections, the latest developments in clinical microbiology.  It aims to discuss the current state of knowledge in the field, as well perspectives on controversial issues.   It will provide a unique platform for the clinical scientists, young researchers, and consultants in clinical and medical microbiology to exchange current information.

Acknowledging the rapid advancements in molecular haematology, this medically-led and clinically focused conference aims to discuss a high-level of clinical and scientific guidance and support around test choice and test interpretation.  This will include educational sessions in different aspects of haematopathology, haemoglobinopathies, coagulation, haemostasis and will also address everyday quality challenges in the haematology lab.

The development of accurate POC testing and its impact on new disease areas and disease management presents many challenges for healthcare providers.  Regulatory aspects, validation, and clinical applications must be considered when discussing the integration of POC. Join academic and industry leaders to discuss the issues with applications and success rates of POC testing platforms and disease management.

Fime 2017 Highlights